Early postnatal dexamethasone influences matrix metalloproteinase-2 and -9, and their tissue inhibitors in the developing rat lung

Pediatric Pulmonology

Volumn 35, Issue 6, 2003, Pages 456-462

  Valencia, Arwin M ^a,b   Beharry, Kay D ^c   Ang, Jorge G ^a,b   Devarajan, Kamakshi ^a,b   Van Woerkom, Richard ^a,b   Abrantes, Maria ^a,b   Nishihara, Kenji ^c   Chang, Eileen ^c   Waltzman, Joshua ^c   Modanlou, Houchang D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Dexamethasone; Lung; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases

Indexed keywords

DEXAMETHASONE; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; LUNG ALVEOLUS MACROPHAGE; LUNG DEVELOPMENT; LUNG VOLUME; MICROVASCULATURE; NONHUMAN; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; DEXAMETHASONE; IMMUNOHISTOCHEMISTRY; LUNG; MATRIX METALLOPROTEINASE 2; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0038350760     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10293     Document Type: Article

References (39)

1. Halliday HL, Ehrenkranz RA. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane review). Cochrane Database Syst Rev 2001;1:CD001144.
2. Arias-Camison JM, Lau J, Cole CH, Frantz ID III. Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 1999;28:167-174.
3. Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1998;79:26-33.
4. Tschanz SA, Damke BM, Burri PH. Influence of postnatally administered glucocorticoids on rat lung growth. Biol Neonate 1995;68:229-245.
5. Massova I, Kotra LP, Fridman R, Mobasher S. Matrix metalloproteinases: structure evolution and diversification. FASEB J 1998;12:1075-1095.
6. Woessner J Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
7. Matrisan LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-463.
8. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-524.
9. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. Bioassays 1989;14:455-463.
10. Fukuda Y, Ferran VJ, Crystal RG. The development of alveolar septa in fetal sheep lung: ultrastructural and immunohistochemical study. Am J Anat 1983;167:405-439.
11. Heine UI, Munoz EF, Flanders KC, Roberts AB, Spora MB. Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. Development 1990;109:29-36.
12. Roman J, McDonald JA. Expression of fibronectin, the intedrin alpha 5, and alpha-smooth muscle action in heart and lung development. Am J Respir Cell Mol Biol 1992;6:472-480.
13. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9, and tissue inhibitor of metalloproteinases-2 in interstitial lung diseases. Lab Invest 1998;78:687-698.
14. Katzentein AL, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
15. Crouch E. Pathobiology and pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 1990;259:159-184.
16. Raghu G, Striker L, Hudson LD, Striker GE. Extracellular matrix in normal and fibrotic lungs. Am Rev Respir Dis 1985;131:281-289.
17. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
18. Seiki M. Membrane-type matrix metalloproteinases. Acta Pathol Microbiol Immunol Scand 1999;107:137-143.
19. Woessner JF Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21.
20. Baker AH, Zaltsman AB, George SJ, Reuby AC. Divergent effects of tissue inhibitor of metalloproteinases-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998;101:1478-1487.
21. Gomez D, Alonzo D, Yoship U, Thorgeinsson P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-122.
22. Guedez L, Stetler-Stevenson WG, Wolff L, Wang L, Fukushima P, Mansoor A, Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998;102:2002-2010.
23. Institute of Laboratory Animal Resources Commission on Life Sciences. National Research Council. The guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
24. American Veterinary Medical Association. Implementation of the Revised American Veterinary Medical Association Panel on Euthanasia report. Bethesda, MD: National Institutes of Health; 2001.
25. Planus E, Galiacy S, Matthew M, Laurent V, Gavrilovic J, Murphy G, Clerici C, Isabey D, Lafuma C, d'Ortho MP. Role of collagenase in mediating in vitro alveolar epithelial wound repair. Cell Sci 1999;112:243-252.
26. Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P. Postnatal development of alveoli: regulation and evidence for a critical period in rats. J Clin Invest 1985;76:1297-1305.
27. Vliagoftis H, Schwingshackl A, Milne CD, Duszyk M, Hollenberg MD, Wallace JL, Befus AD, Moqbel R. Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 2000;106:537-545.
28. Shapiro SD, Kobayashi DK, Welgus HG. Identification of IMP-2 in human alveolar macrophages. J Biol Chem 1992;267:13890-13894.
29. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997;17:583-591.
30. Buckley S, Driscoll B, Shi W, Anderson K, Warburton D. Migration and gelatinases in cultured fetal, adult, and hyperoxic alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2001;281:427-434.
31. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. Dexamethasone selectively modulates basal and lipopolsaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 1991;146:2724-2729.
32. Brummer E, Maqbool A, Stevens DA. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia. Med Mycol 2001;39:509-515.
33. Gonzales LW, Guttentag SH, Wade KC, Postle AD, Ballard PL. Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP. Am J Physiol Lung Cell Mol Physiol 2002;283:940-951.
34. Okajima S, Matsuda T, Cho K. Antenatal dexamethasone impairs normal postnatal lung growth in rats. Pediatr Res 2001;49:777-781.
35. Stark AR, Carlo WA, Tyson JE, Papile L-A, Wright LL, Shankaran S, Donovon EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll BJ. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. N Engl J Med 2001;344: 95-101.
36. Banks BA. Postnatal dexamethasone for bronchopulmonary dysplasia: a systemic review and meta-analysis of 20 years of clinical trials. Neoreviews 2002;3:24-34.
37. O'Connor CM, FitzGerald MX. Matrix metalloproteases and lung disease. Thorax 1994;49:602-609.
38. Thurlbeck WM. Lung growth and development. In: Thulbeck WM, Chung AM, editors. Pathology of the lung, 2nd ed. New York: Thieme Medical Publishers; 1995. p 37-87.
39. Burri PH. The postnatal growth of rat lung: III. Morphology. Anat Rec 1974;180:77-98.